期刊文献+

阿霉素对sw480细胞端粒酶活性的影响 被引量:1

阿霉素对sw480细胞端粒酶活性的影响
下载PDF
导出
摘要 目的观察不同浓度阿霉素对大肠癌sw480细胞端粒酶活性的影响,探讨不同阿霉素作用浓度与端粒酶活性之间的关系,进而探讨阿霉素通过稳定G-四联体达到抑制肿瘤细胞增殖的可能性。方法培养sw480细胞,取对数生长期sw480细胞制成不同浓度细胞悬液,通过MTT法测定不同浓度阿霉素对sw480细胞的增殖抑制率;通过PCR-TRAT-Elisa检测不同浓度阿霉素作用下大肠癌sw480细胞的端粒酶活性。结果 MTT结果显示,阿霉素抑制sw480细胞增殖具有浓度和时间依赖性;随着阿霉素处理作用时间延长,实验组细胞端粒酶活性逐渐降低,72h后达到最低。结论阿霉素抑制sw480细胞端粒酶活性具有明显的时间和浓度依赖性,其机制可能与阿霉素稳定G四联体有关。 Objective To observe the effects of adramycin on telomerase activity of sw480 ceels,and to evaluate the relationship of the different concentration and activity of telomerase of sw480 cells,and to evaluate the possibility that adramycin restrain the proliferation of sw480 cells.Methods Cultured the sw480 cells,The effective concentration of adramycin in the experiments was determined by using methylthiazolyl tetrazolium(MTT) assay of sw480 cells,The changes of telomerase activity in sw480 cells was detected by PCR-TRAT-Elisa.Results The result of MTT declare that the effective concentration of adramycin in the subsequent experiments was determined as 5μmol/L;The activitys of telomerase of sw480 droped as the time of experiment,being the lowest at 72hours group.Conclusion Adramycin lead to inhibition of telomerase activity in sw480 cells,and the leading is determined by concentration of adramycin an the experimental time.The poosibility mechanism is adramycin's inducing telomere to form G-quadruplex structure.
出处 《当代医学》 2012年第12期40-41,共2页 Contemporary Medicine
基金 山东省高校科技计划项目(J11LF74)
关键词 阿霉素 SW480细胞 端粒酶 Adramycin Sw480cells Telomerase
  • 相关文献

参考文献4

二级参考文献21

  • 1Shengqi Wang,Li Lin,Zhongbin Chen,Ruxian Lin,Suhong Chen,Wei Guan,Xiaohong Wang.Effect of antisense oligonucleotides targeting telomerase catalytic subunit on tumor cell proliferation in vitro[J].Chinese Science Bulletin,2002,47(12):993-997. 被引量:10
  • 2何敏,蒋玉艳,朱淼,韦霄,覃健,张志勇,李力.AZT对肝癌细胞端粒酶活性及相关蛋白表达的影响[J].癌症,2006,25(5):543-548. 被引量:6
  • 3金正均.合并用药中的相加[J].中国药理学报,1980,1:70-73.
  • 4[1]Kelland LR.Telomerase inhibitors: targeting the vulnerable end of cancer[J]? Anticancer Drugs,2000,11(7):503-513.
  • 5[2]Kiyozuka Y,Yamamoto D,Yang J,Uemura Y,Senzaki H,Adachi S,et al.Correlation of chemosensitivity to anticancer drugs and telomere length,telomerase activity and telomerase RNA expression in human ovarian cancer cells[J].Anticancer Res,2000,20(1A):203-212.
  • 6[3]Faraoni I,Graziani G,Turriziani M,Masci G,Mezzetti J,Testori A,et al.Suppression of telomerase activity as an indicator of drug-induced cytotoxicity against cancer cells: in vitro studies with fresh human tumor samples[J].Lab Invest,1999,79(8):993-1005.
  • 7[4]Faraoni I,Turriziani M,Masci G,De Vecchis L,Shay JW,Bonmassar E,et al.Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro[J].Clin Cancer Res,1997,3(4):579-585.
  • 8[5]Burger AM,Double JA,Newell DR.Inhibition of telom- erase activity by cisplatin in human testicular cancer cells[J].Eur J Cancer,1997,33(4):638-644.
  • 9[6]Kim NW,Piatyszek MA,Prowse KR,Harley CB,West MD,Ho PL,et al.Specific association of human telomerase activity with immortal cells and cancer[J].Science,1994,266(5193):2011-2015.
  • 10[7]Sumida T,Hamakawa H,Sogawa K,Sugita A,Tanioka H,Ueda N.Telomerase components as a diagnositic tool in human oral lesions[J].Int J Cancer,1999,80(1):1-48.

共引文献20

同被引文献17

  • 1Davis L, Maizels N. G4 DNA: at risk in tile genome[J]. EMBO J, 2011,30(19) :3878-3879.
  • 2Gift B, Smaldino PJ, Thys RG, et al. G4 resolvase 1 tightly binds and unwinds unimotecular G4-DNA[ J]. Nucleic Acids Res, 2011, 39(16) :7161-7178.
  • 3Membrino A, Cogoi S, Pedersen EB, et al. G4-DNA formation in the HRAS promoter and rational design of decoy oligonucleotides for cancer therapy[ J]. PLoS One, 2011,6(9) :p. e24421.
  • 4Lubitz I, Kotlyar A. G4-DNA-eoated gold nanoparticles: synthesis and assembly[ J]. Bioconjug Chem, 2011,22(10) :2043-2047.
  • 5Singh V, Benz A, Hartig .IS. G quadruplexes stahilised by 8-oxn-2'- deoxyguanosine[ J ]. Chemistry, 2011 , 17 ( 39 ) : 10838-10843.
  • 6Yuan NB, Long Y, Zhang X, et al. Study on the mechanism of au- tologous platelet-rich gel to treat the refractory diabetic dermal ulcers [J]. Sichuan Da Xue Xue Bao Yi Xue Ban, 2009,40(2) :292-294.
  • 7Chen Y, Agrawal P, Brown RV. The major G-quadruplex formed in the human platelet-derived growth factor receptor beta promoter adopts a novel broken-strand structure in K + solution [ J ]. J Am Chem Soc, 2012,134 (32) : 13220-13223.
  • 8Juranek SA, Paeschke K. Cell cycle regulation of G-quadruplex DNA structures at telomeres[ J]. Curr Pharm Des, 2012,18 ( 14 ) : 1867-1872.
  • 9Onyshchenko MI, Gaynutdinov TI, Englund EA, et al. Quadru- plex formation is necessary for stable PNA invasion into duplex DNA of BCL2 promoter region [ J]. Nucleic Acids Res, 2011,39 (16) :7114-7123.
  • 10Smith FW, Feigon J. Quadruplex structure of Oxytficha telomeric DNA oligonucleotides[ J]. Nature, 1992,356(6365) : 164-168.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部